norfloxacin has been researched along with Renal Artery Stenosis in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Excerpt | Relevance | Reference |
---|---|---|
" The mean serum elimination half-life was 8." | 1.27 | [Human and animal studies on the pharmacokinetics of norfloxacin in renal failure]. ( Akaba, K; Irikura, T; Kusajima, H; Miyahara, T; Saito, A; Shimada, J; Uchida, H, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shimada, J | 1 |
Saito, A | 1 |
Akaba, K | 1 |
Miyahara, T | 1 |
Kusajima, H | 1 |
Uchida, H | 1 |
Irikura, T | 1 |
1 other study available for norfloxacin and Renal Artery Stenosis
Article | Year |
---|---|
[Human and animal studies on the pharmacokinetics of norfloxacin in renal failure].
Topics: Administration, Oral; Adult; Aged; Animals; Bile; Female; Half-Life; Humans; Injections, Intravenous | 1986 |